Delivery Order SPE2DR25D1205-SPE2DR26F0VM5
- Not listed
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 9, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The contract is set to be completed by October 14, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical product, valued at $9,975.58, with a firm fixed price structure. This delivery order, issued on May 6, 2025, is classified as a child contract under a larger vehicle and carries an ultimate completion date of May 28, 2025. The award represents a non-competitive delivery order executed under AmerisourceBergen's existing indefinite delivery contract framework...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. This $6,165.34 firm fixed price delivery order is scheduled for completion by September 3, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed price contract with an ultimate completion date of August 14, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $15,407.08 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on September 12, 2025, with a completion date of October 3, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $12,330.68 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector pharmaceutical supply. The contract, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $12,330.68 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 22, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VM5Delivery Order
The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 12, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying pharmaceuticals and medical supplies to support military and veteran healthcare systems. The Benlysta auto-injector is a specialty pharmaceutical used in the treatment of lupus and is one of numerous therapeutic products the company delivers through its comprehensive DLA contract vehicle. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in meeting competitive procurement requirements and managing both high-value and smaller-value pharmaceutical delivery orders across multiple therapeutic domains for the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 10/21/25 |